Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03507452 |
| Title | First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Bayer |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | NLD | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| National Cancer Institute - Maryland | Bethesda | Maryland | 20892 | United States | Details | |
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| HUS, Meilahden sairaala | Helsinki | 00290 | Finland | Details | ||
| Nederlands Kanker Instituut | Amsterdam | 1066 CX | Netherlands | Details | ||
| Universitair Medisch Centrum Groningen | Groningen | 9713 GZ | Netherlands | Details | ||
| Skånes Universitetssjukhus | Lund | 221 85 | Sweden | Details | ||
| Royal Marsden NHS Trust (Surrey) | Sutton | Surrey | SM2 5PT | United Kingdom | Details |